Skip to main content

Table 4 Multivariate analysis

From: FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients

Characteristics

DFI (global test p = 0.5497)a

DSS (global test p = 0.7496)a

HR

CI

P

HR

CI

P

Age

0.99

0.97–1.02

0.703

0.99

0.96–1.04

0.844

Size ≥ 15 mm

2.40

1.00–5.78

0.050

5.40

0.65–44.6

0.117

Lymph node involvement

 0

1

 

 1

2.01

0.89–4.52

0.090

1.23

0.27–5.54

0.790

 2

4.24

1.68–10.7

0.002

4.27

1.07–17.0

0.040

 3

6.34

2.24–17.9

0.001

6.58

1.45–29.9

0.015

KI67 ≥ 20%

2.58

1.19–5.58

0.016

4.27

0.88–20.7

0.071

FOXA1

0.24

0.08–0.74

0.013

0.34

0.04–3.08

0.340

  1. Association of tumor characteristics with disease free interval (DFI) and disease specific survival (DSS) among ER+ patients with complete data for all covariates
  2. aTest of proportional-hazards assumption
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us